In this issue:
Alcohol and smoking-associated psoriasis risk in postmenopausal women
Risankizumab for generalised pustular or erythrodermic psoriasis
Calcipotriene/betamethasone dipropionate foam for psoriasis in skin of colour
Secukinumab long-term use in psoriasis
COVID-19 vaccination in patients with immune-mediated dermatological diseases
Guselkumab for plaque psoriasis with baseline IGA Score ≥2
Guselkumab for psoriasis in Chinese patients
Secukinumab effect across different body regions
Real-world effectiveness of guselkumab in plaque psoriasis
Please login below to download this issue (PDF)